Optic Nerve Atrophy: Use with caution in patients with Leber's diseasea type of hereditary optic nerve atrophyas it may worsen the condition
The dosage chart presented here provides a framework, but the clinical nuances, specifically the titration pace, the dose ceiling, the choice of synergistic agents, and the biomarker monitoring schedule, should be individualized by a physician familiar with both the patient's metabolic history and the evolving evidence base for mitochondrial peptide therapy
Below, we outline major potential applications, integration into protocols, duration considerations, and patient populations, along with concrete examples and caveats
This neuroprotective effect is especially relevant for disc herniations where nerve compression is the primary source of symptoms